Veterinary API Market Revenue to Attain USD 8.40 Bn by 2033

26 Jun 2025

Share :

Table of Content

1. Veterinary API Market Revenue and Trends 2025 to 2033 2. Global Veterinary API Market Outlook: Growth Factors and Opportunities 3. Segment Outlook 4. Regional Insights 5. Veterinary API Market Coverage 6. Veterinary API Market Key Players

Veterinary API Market Revenue and Trends 2025 to 2033

The global veterinary API market revenue surpassed USD 5.62 billion in 2025 and is predicted to attain around USD 8.40 billion by 2033, growing at a CAGR of 5.14%. This market is growing at a rapid pace due to the significant increase in demand for animal health solutions, driven by increased livestock production and pet ownership. The growing focus on preventing the spread of zoonotic diseases further contributes to market expansion.

Global Veterinary API Market Outlook: Growth Factors and Opportunities

The veterinary API market is experiencing robust growth, fueled by several key trends. A notable trend in the market is the rising humanization of pets, which encourages pet owners to invest heavily in high-quality pharmaceuticals. The rising global demand for animal-source food products creates pressure to improve animal health and productivity. Moreover, increasing awareness of pet healthcare and spikes in pet ownership are driving the demand for treatments and effective veterinary medicines.

Technological innovations in formulation and expansions of livestock farming in emerging economies create immense opportunities in the market. In addition, the increasing healthcare costs are urging pet owners to invest in effective and high-quality pharmaceuticals that support preventative care. With the growing prevalence of chronic diseases in animals and zoonotic diseases, there is a need for preventative treatments, contributing to market growth.

Segment Outlook

• By service type, the in house manufacturing segment held the largest share of the market in 2024. Due to stringent regulations regarding quality, pharmaceutical manufacturers often prefer in-house manufacturing as it allows them to have more control over quality, ensuring compliance with regulatory standards. The increased demand for bespoke, highly purified APIs bolstered the segment.
• By synthesis type, the chemical-based API segment accounted for the largest market share in 2024. This is mainly due to their proven effectiveness in treating infection or relieving pain. Chemical-based APIs are widely preferred for their established manufacturing processes and cost-effectiveness.
• By animal type, the production animals segment led the market in 2024. This is mainly due to the increased production of cattle, poultry, and swine. The increasing demand for meat products and the prevalence of zoonotic diseases creates the need for high-quality APIs for production animals.
• By therapeutics, the anti-infectives segment contributed the largest market share in 2024. The growth of the segment is driven by the increased demand for antibiotics and antimicrobials for the treatment of ubiquitous infections in production animals and companion animals, driven by increased prevalence of zoonotic disease.

Regional Insights

North America is a leader in the veterinary API market due to its well-developed animal health system, presence of leading pharmaceutical companies, and growing awareness of animal disease management. There is high demand for quality pharmaceuticals, driven by increased pet humanization. Advancements in animal therapeutics further contribute to regional market growth.

Asia Pacific is expected to experience the fastest growth in the coming years. The growth of the market in the region is attributed to the growing livestock farming, extensive investments in veterinary health, and the increasing number of pet owners, especially in developing economies like India, China, and Japan. The rising disposable income is enabling pet owners to spend on pet care products, supporting market expansion.

Veterinary API Market Coverage

Recent Development

• In January 2024, the European Commission released two draft implementing regulations: GMP for APIs used in veterinary medicinal products and GMP for veterinary medicinal products. GMP for veterinary medicinal products ensures the quality and safety of pharmaceuticals for animals.
  (Source: https://www.nsf.org)

Veterinary API Market Key Players

• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health, Bayer Animal Health
• Alivira Animal Health Ltd.
• Chempro Pharma Pvt. Ltd.
• Elanco
• Excel Industries Ltd.
• MENADIONA
• Ofichem Group
• Qilu Animal Health Products Co., Ltd.
• Siflon Drugs
• SUANFARMA
• Vetpharma
• Zoetis

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6292

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344